Benjamin L Handen

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. ncbi request reprint A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder
    Antonio Y Hardan
    Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    J Child Adolesc Psychopharmacol 12:237-41. 2002
  2. ncbi request reprint Practitioner review: Psychopharmacology in children and adolescents with mental retardation
    Benjamin L Handen
    Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    J Child Psychol Psychiatry 47:871-82. 2006
  3. ncbi request reprint Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder
    Benjamin L Handen
    Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15203, USA
    Int J Adolesc Med Health 23:167-73. 2011
  4. pmc Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B
    Benjamin L Handen
    Department of Psychiatry, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Alzheimers Dement 8:496-501. 2012
  5. pmc Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures
    Benjamin L Handen
    Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15203, USA
    J Child Adolesc Psychopharmacol 21:43-50. 2011
  6. doi request reprint A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder
    Benjamin L Handen
    University of Pittsburgh School of Medicine, Pittsburgh, PA 15203, USA
    J Autism Dev Disord 39:796-805. 2009
  7. doi request reprint Guanfacine in children with autism and/or intellectual disabilities
    Benjamin L Handen
    University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    J Dev Behav Pediatr 29:303-8. 2008
  8. ncbi request reprint Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders
    Antonio Y Hardan
    Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh 15213, USA
    J Autism Dev Disord 35:387-91. 2005
  9. ncbi request reprint Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders
    Roger J Jou
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    J Child Adolesc Psychopharmacol 15:325-30. 2005
  10. pmc Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials
    Cynthia R Johnson
    University of Pittsburgh School of Medicine, Children s Hospital of Pittsburgh, Autism Center, 3705 5th Avenue, Pittsburgh, PA 15213, USA
    J Intellect Dev Disabil 34:230-8. 2009

Detail Information

Publications12

  1. ncbi request reprint A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder
    Antonio Y Hardan
    Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    J Child Adolesc Psychopharmacol 12:237-41. 2002
    ..Double-blind, placebo-controlled investigations are needed to provide further evidence of the potential benefits of donepezil to patients with autistic disorder...
  2. ncbi request reprint Practitioner review: Psychopharmacology in children and adolescents with mental retardation
    Benjamin L Handen
    Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    J Child Psychol Psychiatry 47:871-82. 2006
    ..The purpose of this review is to provide an overview of the recent literature regarding the use of psychotropic medications in this population, focusing primarily on children and adolescents...
  3. ncbi request reprint Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder
    Benjamin L Handen
    Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15203, USA
    Int J Adolesc Med Health 23:167-73. 2011
    ..This paper summarizes the data on a range of pharmacological options and provides specific recommendations for how best to clinically manage these symptoms...
  4. pmc Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B
    Benjamin L Handen
    Department of Psychiatry, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Alzheimers Dement 8:496-501. 2012
    ..These results demonstrate the feasibility of conducting PiB positron emission tomography scanning in this special population, and suggest a link between Aβ overproduction and early striatal deposition of fibrillar Aβ...
  5. pmc Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures
    Benjamin L Handen
    Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15203, USA
    J Child Adolesc Psychopharmacol 21:43-50. 2011
    ..The goal of this study was to assess the tolerability, safety, and efficacy of donepezil on EF in a sample of children and adolescents with ASD...
  6. doi request reprint A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder
    Benjamin L Handen
    University of Pittsburgh School of Medicine, Pittsburgh, PA 15203, USA
    J Autism Dev Disord 39:796-805. 2009
    ..This study demonstrates the importance of conducting rigorous trials in children with autism and casts doubt on one GI mechanism presumed to exert etiological and/or symptomatic effects in this population...
  7. doi request reprint Guanfacine in children with autism and/or intellectual disabilities
    Benjamin L Handen
    University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    J Dev Behav Pediatr 29:303-8. 2008
    ..In addition, evidence suggests that children with developmental disabilities experience higher rates of adverse events. Guanfacine, an alpha2-adrenergic receptor agonist, has shown some promise as an alternative to psychostimulants...
  8. ncbi request reprint Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders
    Antonio Y Hardan
    Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh 15213, USA
    J Autism Dev Disord 35:387-91. 2005
    ..Quetiapine may be beneficial in children and adolescents with pervasive developmental disorders, however open-label and double-blind, placebo-controlled studies are warranted...
  9. ncbi request reprint Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders
    Roger J Jou
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    J Child Adolesc Psychopharmacol 15:325-30. 2005
    ..Atomoxetine may be beneficial for treating secondary symptoms of PDD, and prospective open-label or double-blind, placebo-controlled studies are needed to assess its efficacy and safety...
  10. pmc Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials
    Cynthia R Johnson
    University of Pittsburgh School of Medicine, Children s Hospital of Pittsburgh, Autism Center, 3705 5th Avenue, Pittsburgh, PA 15213, USA
    J Intellect Dev Disabil 34:230-8. 2009
    ..We report on the use of this procedure in a pilot study of 12 participants with PDD...
  11. ncbi request reprint Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavioral disorders
    Benjamin L Handen
    University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic, Pittsburgh, PA 15203, USA
    J Am Acad Child Adolesc Psychiatry 45:928-35. 2006
    ..This prospective, open-label study was conducted to examine the safety and usefulness of olanzapine in treating disruptive behavior disorders in adolescents with subaverage intelligence...
  12. ncbi request reprint A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders
    Antonio Y Hardan
    Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    J Child Adolesc Psychopharmacol 14:426-32. 2004
    ..Topiramate may be beneficial for treating secondary symptoms of PDD, and prospective openlabel studies and double-blind, placebo-controlled studies to assess its efficacy and safety are needed...